Apellis Pharmaceuticals (APLS) stock valuation

$41.03 Jun 12, 2026 · market cap $5.3B

0/121 investors
i

Apellis Pharmaceuticals trades at $41. We don't have a valuation for it yet.

None of the 121 investors we track holds it

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate APLSCreate free account →

Full open-source research report for APLS on DeepValues Research (CC BY 4.0)